Evidence map›Paper›PMID 40662810›Full record

ArticleBioinformatics (Oxford, England)2025

TCR-epiDiff: solving dual challenges of TCR generation and binding prediction.

Se Yeon Seo, Je-Keun Rhee

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Peptide-based drug design using generative AI.Chemical communications (Cambridge, England) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Se Yeon SeoDepartment of Bioinformatics & Life Science, Soongsil University, Seoul 06978, Korea.
Je-Keun RheeDepartment of Bioinformatics & Life Science, Soongsil University, Seoul 06978, Korea.ORCID 0000-0003-4811-8895

Funding

Ministry of Education RS-2021-NR060140Ministry of Science and ICT RS-2021-NR061451Ministry of Science and ICT RS-2022-NR067277National Research Foundation of Korea
6 · The paper itself

Abstract

motivationT cell receptors (TCRs) are fundamental components of the adaptive immune system, recognizing specific antigens for targeted immune responses. Understanding their sequence patterns is crucial for designing effective vaccines and immunotherapies. However, the vast diversity of TCR sequences and complex binding mechanisms pose significant challenges in generating TCRs that are specific to a particular epitope.

resultsHere, we propose TCR-epiDiff, a diffusion-based deep learning model for generating epitope-specific TCRs and predicting TCR-epitope binding. TCR-epiDiff integrates epitope information during TCR sequence embedding using ProtT5-XL and employs a denoising diffusion probabilistic model for sequence generation. Using external validation datasets, we demonstrate the ability to generate biologically plausible, epitope-specific TCRs. Furthermore, we leverage the model's encoder to develop a TCR-epitope binding predictor that shows robust performance on the external validation data. Our approach provides a comprehensive solution for both de novo generation of epitope-specific TCRs and TCR-epitope binding prediction. This capability provides valuable insights into immune diversity and has the potential to advance targeted immunotherapies. AVAILABILITY AND IMPLEMENTATION: The data and source codes for our experiments are available at: https://github.com/seoseyeon/TCR-epiDiff.

Indexed as

Computational BiologyDeep LearningReceptors, Antigen, T-CellSoftwareEpitopesEpitopes, T-LymphocyteHumansProtein BindingEpitopesEpitopes, T-LymphocyteReceptors, Antigen, T-Cell

Identifiers

PMID40662810
PMCPMC12261488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.